J&J MedTech is restructuring its DePuy Synthes orthopedics unit
Johnson & Johnson MedTech is restructuring its DePuy Synthes orthopedic unit, executives said on a quarterly earnings call with investors.
Stay updated with breaking news from Johnson Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson MedTech is restructuring its DePuy Synthes orthopedic unit, executives said on a quarterly earnings call with investors.
At DeviceTalks West this week, we’ll explore the design, economics and broader opportunities for surgical robotics.
COVID-19 health care costs are significantly greater than those for influenza and pneumonia. Treatment costs for severe COVID-19 exceed those for influenza and pneumonia by approximately $50,000.
The FDA wrote Abiomed up for its response to problems with the heart pump and for selling its Impella Connect System without approval.
For all the talk around what digital can accomplish in medtech, questions remain, experts said today at AdvaMed's The MedTech Conference.